Ignite Creation Date:
2024-05-05 @ 11:42 PM
Last Modification Date:
2024-10-26 @ 10:37 AM
Study NCT ID:
NCT01390337
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2011-07-07
Brief Title:
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia AML
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia Myeloid Acute |
Keywords:
| Name | View |
|---|---|
| quizartinib | View |
| AC220 | View |
| Acute Myeloid Leukemia AML | View |
| De Novo Acute Myeloid Leukemia AML | View |
| Newly diagnosed Acute Myeloid Leukemia AML | View |
| FMS-like tyrosine kinase FLT3 | View |
| FMS-like tyrosine kinase FLT3 Inhibitor | View |
| Kinase | View |
| Kinase Inhibitor | View |
| Pharmacokinetics | View |
| ASP2689 | View |